Company
Supira Medical
Developing a low-profile, high continuous flow percutaneous ventricular assist device (pVAD) for high risk PCI and cardiogenic shock.
Also known as Supira Medical, Inc.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Supira Medical, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Supira Medical, a clinical-stage Shifamed portfolio company, is focused on development of a next-generation pVAD for use in high-risk patients undergoing interventional procedures or experiencing cardiogenic shock.
Funding snapshot
- Total raised
- $221MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $120M2025-03-25
Funding rounds
- Round, 2025
- $120M2025-03-25, SEC form D sold, 20 investors
- Round, 2023
- $21.1M2023-11-17, SEC form D sold, 22 investors
- Round, 2022
- $30M2022-02-25, SEC form D sold, 31 investors
- Round, 2020
- $35.1M2020-02-25, SEC form D sold, 31 investors
- Round, 2018
- $12.9M2018-04-25, SEC form D sold, 24 investors
- Round, 2017
- $1.6M2017-12-07, SEC form D sold, 15 investors
Products
- Hardware
- Supira Medical's Next Generation pVAD Product
Loading relationship preview